MiniMed rises after Q4 revenue beat
03/06/2026 15:10
BUZZ-MiniMed rises after Q4 revenue beat Updates
** Shares of diabetes care company MiniMed MMED.O rise 9.1% to $13.4
** MMED posts Q4 net sales of $837 million, above analysts' estimates of $827.3 million - data compiled by LSEG
** Reports 2026 sales of $3.1 billion, above analysts' estimates of $3.08 billion
** Expects organic revenue growth of about 10% for fiscal year 2027
** Analysts on an average expect 2027 revenue to be $3.4 billion
** Brokerage Evercore ISI says, "We continue to view shares as attractive in light of the valuation vs. growth"
** As of last close, stock MMED down 33.5% since its IPO in March
(Reporting by Siddhi Mahatole)